In vitro performance of 13-93 bioactive glass fiber and trabecular scaffolds with MLO-A5 osteogenic cells

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 10, 2012, Pages 2593-2601

  Modglin, Vernon C ^a   Brown, Roger F ^a   Fu, Qiang ^b   Rahaman, Mohamed N ^c   Jung, Steven B ^c   Day, Delbert E ^c  

^a MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c Architectural and Environmental Engineering   (United States)

Author keywords

alkaline phosphatase; glass fibers; osteoblasts; proliferation; scaffolds

Indexed keywords

ALKALINE PHOSPHATASE; BONE FORMATION; BONE TISSUE ENGINEERING; CELL DENSITY; CELL DIFFERENTIATION; EXTRACELLULAR; IN-VITRO; KEY INDICATOR; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC CELLS; POROUS BIOACTIVE GLASS; PROLIFERATION; PROTEIN MEASUREMENT;

BIOACTIVE GLASS; BONE; CELL CULTURE; FIBERS; GLASS FIBERS; OSTEOBLASTS; PHOSPHATASES; SCAFFOLDS; SCANNING ELECTRON MICROSCOPY;

SCAFFOLDS (BIOLOGY);

ALIZARIN; ALKALINE PHOSPHATASE; GLASS FIBER; TISSUE SCAFFOLD;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL DENSITY; CELL DIFFERENTIATION; CELL LINE; CELL TYPE; INCUBATION TEMPERATURE; MINERALIZATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; SCANNING ELECTRON MICROSCOPY; STAINING; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; ANIMALS; ANTHRAQUINONES; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ASSAYS; GLASS; HUMANS; MATERIALS TESTING; MICE; OSTEOBLASTS; OSTEOGENESIS; STAINING AND LABELING; TISSUE SCAFFOLDS;

EID: 84865648881     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34195     Document Type: Article

References (30)

1. Younger EM, Chapman MW,. Morbidity at bone graft donor sites. J Orthop Trauma 1989; 3: 192-195.
2. Summers BN, Eisenstein SM,. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg [Br] 1989; 71: 677-680. (Pubitemid 19211233)
3. Burg KJL, Porter S, Kellam JF,. Biomaterial developments for bone tissue engineering. Biomaterials 2000; 21: 2347-2359.
4. Aaron AD, Wiedel JD,. Allograft use in orthopedic surgery. Orthopedics 1994; 17: 41-48. (Pubitemid 24029475)
5. Langer R, Vacanti JP,. Tissue engineering. Science 1993; 260: 920-926. (Pubitemid 23209960)
6. Roy TD, Simon JL, Ricci JL, Rekow ED, Thompson VP, Parsons JR,. Performance of hydroxyapatite bone repair scaffolds created via three-dimensional fabrication techniqes. J Biomed Mater Res 2003; 67A: 1228-1237. (Pubitemid 37522736)
7. Hutmacher DW,. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000; 21: 2529-2543.
8. Brown RF, Day DE, Day TE, Jung S, Rahaman MN, Fu Q,. Growth and differentiation of osteoblastic cells on 13-93 bioactive glass fibers and scaffolds. Acta Biomater 2008; 4: 387-396. (Pubitemid 351218086)
9. Fu Q, Rahaman MN, Bal SB, Brown RF, Day DE,. Mechanical and in vitro performance of 13-93 bioactive glass scaffolds prepared by a polymer foam replication technique. Acta Biomater 2008; 4: 1854-1864.
10. Jones JR, Ehrenfried LM, Hench LL,. Optimizing bioactive glass scaffolds for bone tissue engineering. Biomaterials 2006; 27: 964-973. (Pubitemid 41566688)
11. Kellomaki M, Niiranen H, Puumanen K, Ashamamakhi N, Waris T, Tormala P,. Bioabsorbable scaffolds for guided bone regeneration and generation. Biomaterials 2000; 21: 2495-2505.
12. Griffith LG,. Polymeric biomaterials. Acta Mater 2000; 48: 263-277. (Pubitemid 30558407)
13. Borden M, El-Almin SF, Attawia M, Laurencin CT,. Structural and human cellular assessment of a novel microsphere-based tissue engineered scaffold for bone repair. Biomaterials 2003; 24: 597-609. (Pubitemid 35346389)
14. Kneser U, Schaefer DJ, Munder B, Klemt C, Andree C, Stark GB,. Tissue engineering of bone. Min Invas Ther Alli Tech 2002; 11: 107-116. (Pubitemid 34790332)
15. Fuss M, Ehlers EM, Russlies M,. Characteristics of human chondrocytes, osteoblasts and fibroblasts seeded onto a type I/III collagen sponge under different culture conditions. A light, scanning and transmission electron microscopy study. Ann Anat 2000; 182: 303-310. (Pubitemid 30449987)
16. Goldstein SA, Patil PV, Moalli MR,. Perspectives on tissue engineering of bone. Clin Orthop 1999: 357S: S419-S423. (Pubitemid 29501521)
17. Hench LL, Wilson J,. Surface active biomaterials. Science 1984; 226: 630-636.
18. FDA 510(k) Premarket Notification, http://www.accessdata.fda.gov/scrIpts/ cdrh/cfdocs/cfPMN/pmn.cfm?start-search=11&Panel=&Pro ductCode=Lyc&KNumber=K&Model=&Applicant=&DeviceName= &Type=TRADITIONAL&ThirdPartyReviewed=off&ClinicalTrials= off&ExpeditedReview=&Decision=&DecisionDateFrom=&Decision DateTo=&IVDProducts=off&PAGENUM=10&SortColumn=Decision DateDESC.
19. Clupper DC, Mecholsky JJ, La Torre GP, Greenspan DC,. Bioactivity of tape cast and sintered bioactive glass-ceramic in simulated body fluid. Biomaterials 2002; 23: 2599-2606. (Pubitemid 34288499)
20. Brink M,. The influence of alkali and alkaline earths on the working range for bioactive glasses. J Biomed Mater Res 1997; 36: 109-117. (Pubitemid 27271004)
21. Asikainen AJ, Hagstrom J, Sorsa T, Noponen J, Kellomaki M, Juuti H, Lindqvist C, Heitanen J, Suuronen R,. Soft tissue reactions to bioactive glass 13-93 combined with chitosan. J Biomed Mater Res 2006; 83 A: 530-537. (Pubitemid 47557404)
22. Ruuttila P, Niiranen H, Kellomaki M, Tormala P, Konttinen YT, Hukkanen M,. Characterization of human primary osteoblasts response on bioactive glass (BaG 13-93) coated poly-L, DL-lactide (SR-PLA70) surface in vitro. J Biomed Mater Res 2006; 78 B: 97-104.
23. Pirhonen E, Niiranen H, Niemela T, Brink M, Tormala P,. Manufacturing, mechanical characterization, and in vitro performance of bioactive glass 13-93 fibers. J Biomed Mater Res 2006; 77: 227-233. (Pubitemid 43670331)
24. Brink M, Turunen T, Happonen R-P, Yli-Urpo A,. Compositional dependence of bioactivity of glasses in the system Na2O-K2O-MgO-CaO-B2O3-P2O5-SiO2. J Biomed Mater Res 1997; 37: 114-121.
25. Brink M, Yli-Urpo S, Yli-Urpo A,. The resorption of a bioactive glass implanted into rat soft tissue. Presented at the 5th World Biomaterials Congress, Toronto, 1996. 48.
26. Kato Y, Boskey A, Spevak L, Dallas M, Hori M, Bonewald LF,. Establishment of an osteoid preosteocyte-like cell MLO-A5 that spontaneously mineralizes in culture. J Bone Min Res 2001; 16: 1622-1633. (Pubitemid 32786431)
27. Barragan-Adjemian C, Nicolella D, Dusevich V, Dallas MR, Eick JD, Bonewald LF,. Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: Similarities with mineralization of lamellar bone. Calcif Tissue Int 2006; 79: 340-353. (Pubitemid 44900157)
28. Sabokbar A, Millett PJ, Myer B, Rushton N,. A rapid, quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro. Bone Min 1994; 57: 57-67.
29. Gough J, Jones J, Hench LL,. Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 2004; 25: 2039-2046. (Pubitemid 38102404)
30. Park JB, Lakes RS,. Biomaterials: An Introduction, 2nd ed. New York: Plenum Press; 1992. pp 185-222.